Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Biodesix is a leading diagnostic solutions company focused on personalized diagnostics to improve patient care, with a focus on lung disease and early detection. It provides advanced diagnostic tests and custom development services to support biopharma, life sciences, and research institutions in developing diagnostics, tools, and therapeutics (for example Nodify Lung Nodule Risk Assessment and IQLung Cancer Treatment Guidance). The tests have NYS CLEP approval but have not yet been cleared or approved by the FDA.
Parse Score
Sources
ascopubs.org shapes more of what AI says about Biodesix than any other source, at 50% of its citations.
biodesix.com